These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30153065)

  • 1. MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction.
    Syed M; Ball JP; Mathis KW; Hall ME; Ryan MJ; Rothenberg ME; Yanes Cardozo LL; Romero DG
    Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1154-E1167. PubMed ID: 30153065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.
    Ball JP; Syed M; Marañon RO; Hall ME; Kc R; Reckelhoff JF; Yanes Cardozo LL; Romero DG
    Endocrinology; 2017 Jun; 158(6):1859-1874. PubMed ID: 28368454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
    Yoshida K; Kim-Mitsuyama S; Wake R; Izumiya Y; Izumi Y; Yukimura T; Ueda M; Yoshiyama M; Iwao H
    Hypertens Res; 2005 May; 28(5):447-55. PubMed ID: 16156509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.
    Azibani F; Devaux Y; Coutance G; Schlossarek S; Polidano E; Fazal L; Merval R; Carrier L; Solal AC; Chatziantoniou C; Launay JM; Samuel JL; Delcayre C
    PLoS One; 2012; 7(5):e38197. PubMed ID: 22666483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase.
    Makhanova N; Hagaman J; Kim HS; Smithies O
    Hypertension; 2008 Jan; 51(1):134-40. PubMed ID: 18039983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
    Wang K; Long B; Zhou J; Li PF
    J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid antagonism and cardiac hypertrophy.
    Nagata K
    Curr Hypertens Rep; 2008 Jun; 10(3):216-21. PubMed ID: 18765093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
    Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling.
    Li S; Cao W; Wang B; Zhan E; Xu J; Li S
    Clin Sci (Lond); 2020 Jun; 134(12):1319-1331. PubMed ID: 32542395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis.
    Chou CH; Hung CS; Liao CW; Wei LH; Chen CW; Shun CT; Wen WF; Wan CH; Wu XM; Chang YY; Wu VC; Wu KD; Lin YH;
    Cardiovasc Res; 2018 Apr; 114(5):690-702. PubMed ID: 29360942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.
    Katayama IA; Pereira RC; Dopona EP; Shimizu MH; Furukawa LN; Oliveira IB; Heimann JC
    J Nutr; 2014 Oct; 144(10):1571-8. PubMed ID: 25122644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling.
    Sassi Y; Avramopoulos P; Ramanujam D; Grüter L; Werfel S; Giosele S; Brunner AD; Esfandyari D; Papadopoulou AS; De Strooper B; Hübner N; Kumarswamy R; Thum T; Yin X; Mayr M; Laggerbauer B; Engelhardt S
    Nat Commun; 2017 Nov; 8(1):1614. PubMed ID: 29158499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension-induced fibrosis: a balance story].
    Azibani F; Fazal L; Chatziantoniou C; Samuel JL; Delcayre C
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):150-5. PubMed ID: 22681982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet.
    Wang Q; Clement S; Gabbiani G; Horisberger JD; Burnier M; Rossier BC; Hummler E
    Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1178-84. PubMed ID: 14761862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.
    Wang Q; Yu X; Dou L; Huang X; Zhu K; Guo J; Yan M; Wang S; Man Y; Tang W; Shen T; Li J
    Oxid Med Cell Longev; 2019; 2019():8768164. PubMed ID: 31612078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.